Agilux Laboratories is a contract research organization that has been empowering biotech and pharmaceutical advancements with comprehensive bioanalytical and pharmacokinetic testing solutions since 2007. Founded by Peter Glick, the company offers services across discovery, pre-clinical, and clinical stages, specializing in drug metabolism and pharmacokinetics. Their capabilities include discovery bioanalytical, GLP bioanalytical, in vivo, in vitro, and immunoassays, catering specifically to the biotech and pharmaceutical sectors. The company is based in Worcester, Massachusetts, and has received a Seed Round investment in January 2013 from Ampersand Capital Partners. Agilux Laboratories is dedicated to providing comprehensive bioanalytical and PK/PD testing services to support advancements in the biopharma, biotechnology, and pharmaceutical industries.
No recent news or press coverage available for Agilux Laboratories.